These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1475776)

  • 1. An in vitro evaluation of the effect of laser irradiation on the thrombogenicity of thrombus.
    Kundu SK; Ozawa T; Patel RH; McMath LP; Mammen EF; Yellayi S; Spears JR
    Thromb Res; 1992 Oct; 68(2):137-44. PubMed ID: 1475776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
    Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsed laser and thermal ablation of atherosclerotic plaque: morphometrically defined surface thrombogenicity in studies using an annular perfusion chamber.
    Lawrence JB; Prevosti LG; Kramer WS; Smith PD; Bonner RF; Lu DY; Leon MB
    J Am Coll Cardiol; 1992 Apr; 19(5):1091-100. PubMed ID: 1552100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial ultraviolet whole-body radiation does not modify serum lipoprotein, plasma fibrinogen, plasminogen or antithrombin III concentrations in post-myocardial infarction patients.
    Clark P; Cockburn F; Cowan RA; Czapla K; Dunnigan MG; Farish E; Hughes E
    Atherosclerosis; 1994 May; 107(1):65-9. PubMed ID: 7945560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
    Ouweneel AB; Heestermans M; Verwilligen RAF; Gijbels MJJ; Reitsma PH; Van Eck M; van Vlijmen BJM
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):782-785. PubMed ID: 28302625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S; Chen J; Diamond SL
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
    Nishida K; Chiba K; Iwasaki YK; Katsouras G; Shi YF; Blostein MD; Khairy P; Guerra PG; Dubuc M; Tardif JC; Tanguay JF; Nattel S
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1168-75. PubMed ID: 23095228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis.
    Nazli C; Kinay O; Tunc B; Ergene O; Gedikli O; Ayata A; Dogan A; Altinbas A; Ergene U; Ozaydin M; Yavuz T; Kahraman H
    Tex Heart Inst J; 2003; 30(4):268-79. PubMed ID: 14677736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postirradiation changes of plasma coagulation factors and inhibitors of coagulation.
    Klír P; Hlousková D; Pospísil J; Kase F
    Acta Univ Carol Med Monogr; 1987; 119():68-83. PubMed ID: 3324733
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the pathogenesis of hypercoagulability in patients with arterial thrombosis and malignancy].
    Uchiyama T; Andoh K; Tanaka H; Kobayashi N; Naruse T; Maekawa T
    Rinsho Byori; 1990 Jul; Suppl 86():125-33. PubMed ID: 2232233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substitution of antithrombin III by synthetic thrombin inhibitors].
    Hauptmann J; Brüggener E; Müller H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):550-5. PubMed ID: 6083925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
    Levine AB; Teppa J; McGough B; Cowchock FS
    Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thrombin-antithrombin III complexes after 1 h of physical exercise.
    Herren T; Bärtsch P; Haeberli A; Straub PW
    J Appl Physiol (1985); 1992 Dec; 73(6):2499-504. PubMed ID: 1490963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Barrett JA; Crocker AC; Damphousse DJ; Heminway SJ; Liu S; Edwards DS; Lazewatsky JL; Kagan M; Mazaika TJ; Carroll TR
    Bioconjug Chem; 1997; 8(2):155-60. PubMed ID: 9095355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thrombi contain an abundance of active thrombin.
    Mutch NJ; Robbie LA; Booth NA
    Thromb Haemost; 2001 Oct; 86(4):1028-34. PubMed ID: 11686320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different lasers in terms of thrombogenicity of the laser-treated vascular wall.
    Ragimov SE; Belyaev AA; Vertepa IA; Dolgov VV; Furzikov NP; Akchurin RS; Repin VS; Trubetskoy AV
    Lasers Surg Med; 1988; 8(1):77-82. PubMed ID: 3422027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.